Johnson & Johnson to Participate in the UBS Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will attend the UBS Global Healthcare Conference on May 24, 2022.

Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) will attend the UBS Global Healthcare Conference on May 24, 2022. Mathai Mammen, Executive Vice President of Pharmaceuticals R&D, will represent the company during a session at 10:00 a.m. ET. Interested investors can access the live webcast and subsequent replay, which will be available approximately 48 hours later, through the Johnson & Johnson website.

Argus Session date unavailable

-0.29% session move Open Argus

Details

News Market Reaction – JNJ

The recorded move for JNJ in the trading session of this news was -0.29%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW BRUNSWICK, N.J., April 20, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24^th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D, will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48 hours after the live webcast.

View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-ubs-global-healthcare-conference-301529498.html

SOURCE Johnson & Johnson

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Johnson & Johnson participate in the UBS Global Healthcare Conference?

Johnson & Johnson will participate in the UBS Global Healthcare Conference on May 24, 2022.

Who will represent Johnson & Johnson at the UBS Global Healthcare Conference?

Mathai Mammen, Executive Vice President of Pharmaceuticals R&D, will represent Johnson & Johnson.

What time is Johnson & Johnson's session at the UBS Global Healthcare Conference?

Johnson & Johnson's session at the UBS Global Healthcare Conference is scheduled for 10:00 a.m. ET.

How can I access the Johnson & Johnson webcast for the UBS Global Healthcare Conference?

The webcast can be accessed through the Johnson & Johnson website at www.investor.jnj.com.

Will there be a replay of Johnson & Johnson's webcast from the UBS Global Healthcare Conference?

Yes, a replay of the webcast will be available approximately 48 hours after the live event.